
Hosted by The Pulse by Wharton Digital Health · EN

In this episode of the podcast, I sat down with Marta Bralic Kerns, founder and CEO of Pomelo Care, a virtual-first maternity care company delivering high-quality, personalized care to pregnant people and newborns across the United States. Pomelo’s mission is to improve outcomes in maternal and infant health through proactive, data-informed, and accessible care. Marta and I spoke about her path from consulting to founding Pomelo, how she’s scaling care for the most underserved populations, and why she believes we’re only at the beginning of a new era for women’s and children’s health.

Mike Roaldi, President of Cityblock Health, joins us on the Pulse for our latest episode. Cityblock Health is a valued-based primary care company on a mission to radically improve health outcomes for Medicaid and dually eligible populations across the U.S. Cityblock Health is one of the most ambitious care delivery companies today, serving its eligible populations with a tech-enabled, community-rooted approach to care. Prior to Cityblock, Mike built his deep healthcare expertise at UnitedHealth Group, where he spent nearly a decade in executive roles across both UnitedHealthcare and Optum Behavioral Health. In this episode, Mike will share what he believes it takes to serve the most complex, high-need patients in America — and how Cityblock is rethinking trust, tech, and care delivery from the ground up.

Obesity and weight loss are among the most significant and complex challenges facing healthcare today. In our latest episode of The Pulse, we sat down with Evan Richardson, CEO and founder of Form Health, a pioneering virtual obesity medicine clinic. Richardson shared compelling insights about how Form Health is revolutionizing the obesity treatment landscape by delivering personalized, quality care through a robust virtual platform.

In this episode, I sat down with Dr. Rekha Kumar, Chief Medical Officer of Found. Found is one of the first telehealth startups focused on comprehensive obesity care. Since its founding, it has raised over $130 million and was valued at $600 million as of 2022. At the heart of their mission is combining medical treatment — including access to weight-loss medications like GLP-1s — with behavior change support to help people achieve lasting health outcomes.Dr. Kumar is a leading voice in the field of Obesity Medicine. She’s a board-certified endocrinologist, who served as the first Medical Director of the American Board of Obesity Medicine, and is currently a practicing clinician who serves as an associate professor at Weill Cornell.In this episode, we’ll dive into Rekha’s journey from clinical medicine to startup executive, what makes Found’s approach different, and her perspective on access, equity, and the future of GLP-1 therapies.

In this episode of The Pulse Podcast, Vivien interviews Casey Means, Chief Medical Officer and Co-Founder of Levels Health. Levels is a metabolic health company that empowers individuals to radically optimize their health and wellbeing by providing real-time continuous glucose biofeedback coupled with machine learning driven insights to inform personalized diet and lifestyle choices. We discuss the founding journey of Levels, the science of metabolic health, and advice for first-time healthcare entrepreneurs. Levels recently raised $12M of seed funding from Andreessen Horowitz and angel investors including Marc Randolph (co-founder and first CEO of Netflix), Dick Costolo (former CEO of Twitter), Michael Arrington (founder of TechCrunch) and Matt Dellavedova (NBA player on Cleveland Cavaliers).

In this episode of The Pulse Podcast, Vivien interviews Julie Yoo, General Partner at Andreessen Horowitz (a16z), a leading venture capital firm in Silicon Valley that backs bold entrepreneurs building the future through technology. Julie Yoo leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. We cover Julie’s journey from operator to investor, a16z bio’s investment philosophy and how they support their founders, and once in a century trends we are seeing in healthcare’s great unlock.